Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
NCT Number: NCT06171386
This study aims to determine whether microneedling or dermabrasion in the early post-operative period is superior in improving the appearance of surgical scars on the face.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
Microneedling and dermabrasion are two common modalities that may be performed in-office to treat surgical scars.
Microneedling is a form of collagen induction therapy, often used in conjunction with platelet-rich plasma or hyaluronic acid.
Dermabrasion is a technique that improves the skin structure, quality, and appearance of scars through collagen remodeling and reepithelization.
To determine which modality is most effective, a prospective study; randomizing a volunteer sample of adult patients with new surgical vertical forehead scars will receive either dermabrasion or microneedling in the early postoperative period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a form of collagen induction therapy
a technique that improves the skin structure, quality, and appearance of scars through collagen remodeling and reepithelization
Time frame: Month 7
Four characteristics of the scar are assessed. These are: vascularity, height, pliability, and pigmentation. Each characteristic is given a score, which are added together to give an overall score between 0 and 13 - lower scores denoting normal skin
Time frame: Month 7
Items and total scale scores for the patient and observer: Each item on both scales has a score of 1 to 10. The lowest score is 1 and corresponds to the normal skin situation. The total score of both scales can be calculated simply by adding the scores of each of the six items. The total score will range from 6 to 60 - lower scores denoting normal skin
Time frame: Month 7
5-point scale wherein 2 = much improved (marked improvement in appearance), 1 = improved (improvement in appearance but a touch-up or re-treatment is indicated - lower scores denoting normal skin
Time frame: At time of procedure (pain scale); at 6 months (yes/no)
At the time of intervention, patients will be asked to rank pain of procedure on a scale of 1-10 (1: minimal discomfort, 10: severe pain). At 6 months, they will also give a yes/no response as to whether they would undergo the study protocol (procedure) again.
Contact information is provided by the study sponsor or research team.
Alexa l Lacy
CONTACT
Candace M Waters, MD
CONTACT
Wake Forest University Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05408117
Cicatrix, Fibrosis
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07576608
Cicatrix, Fibrosis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06336044
Cicatrix, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Roma, Italy
View Trial DetailsNCT07130747
Cesarean Section Complications, Cicatrix
Alexandria, Egypt
View Trial Details